Alcohol/Ammonia Control is intended for use as an assayed quality control material for ethyl alcohol and ammonia analysis. Features and Benefits - Ready-to-use liquid control requiring no reconstitution or frozen storage. - Once opened, Alcohol/Ammonia Control is stable for 30 days when stored tightly capped at 2-8°C.
For many years, the levels of serum and plasma amylase in patients have provided needed evidence for the diagnosis of acute pancreatitis. Early assay techniques were based on either a change in the absorption maxima of the complex between starch and iodine as the amylase degraded the starch; or a measurement of the increase in reducing groups as the starch was hydrolyzed by the amylase. These methods are not as reliable and easy to quantitate as spectrophotometric methods using a defined substrate. Features and Benefits AMYLASE, DIRECT
- For the quantitative measurement of amylase (a1, 4-glucan-4-glucanohydrolase, E.C.184.108.40.206) activity in serum and plasma. - One part, stable liquid; ready to use reagent. Easy to use, no additional reagent preparation required. - Short reaction time with no lag phase. Faster throughput on automated analyzers. - Excellent precision. Confidence in results. - No significant interferences from triglyceride, glucose, ascorbic acid, bilirubin or hemoglobin. High reliability of testing and fewer re-tests.
The Sekisui family consists of Sekisui Medical Co., LTD which is headquartered in Tokyo, Japan and Sekisui Diagnostics, LLC which is headquartered in Lexington, MA
Sekisui Diagnostics brings together extensive product development capabilities a broad global sales/distribution network and comprehensive product lines:
Clinical Chemistry - SKTM500 Clinical Chemistry System and SEKURETM reagents
Coagulation - CP3000 Coagulation System - Specialty Coagulation Reagents
FastPack® IP Point-of-Care Immunoassay System
Infectious Disease - OSOM® Rapid Tests - Sekisui Virotech LINE immunoassays, and ELISA Kits
Enzymes and Specialty Biochemicals
Sekisui Medical aspires to become a leading global medical company in fields such as Diagnostics, Pharmaceuticals & Fine Chemicals, and ADME & Toxicology Research. Our Diagnostics business is engaged in the development, manufacture, and distribution of plastic vacuum blood collection tubes and various types of in vitro diagnostics products and systems, related primarily to the fields of clinical chemistry, coagulation, lipids, diabetes, rheumatoid arthritis and infectious disease.